Understanding Female Libido and Hormonal Balance

These claims, I should emphasize, are urban myths and have no scientific basis.

What Makes The Pink Pill So Controversial?

In its advocacy at the FDA, Even the Score had insisted that the “score” was twenty-six FDA-approved drugs for men’s dysfunction to zero for women’s. Putting all the drugs in the same register cleverly created the impression of inequity, while also implying that they were equivalent treatments for the same problem. The drugs for men—basically Viagra-type formulations (PDE5 inhibitors), vasodilators, and testosterone—are not central nervous system agents. Nor are they approved to treat sexual desire disorder. Flibanserin is the first and only member of that class.

Non-GMO

Although low sexual desire is allegedly a big problem for men too, medical concern has long focused largely on women. Explanations since the 1990s have been matched to the action of whatever drug was being tested to treat it: a hormone problem, for instance, in the case of testosterone. Hence, low desire is now conceived as a neurochemical imbalance. Driving this home, Even the Score defines HSDD as a “persistent biological lack of desire.” It does not claim that the disorder is unique to women. Talk of a biological lack of desire suggests that there is some normal level of desire in the human body, male and female, and implies that distress might arise directly from this somatic insufficiency. On the surface, the approval of Addyl may look like a step toward gender equality. Its manufacturer, Sprout Pharmaceuticals, did in fact launch a campaign—dubbed “Even the Score”—for its approval, claiming that it would address the inequity of so many drugs for men’s sexual problems and none for women.

Product	Dosage	Quantity + Bonus	Price
Levitra Generic	10mg	90 + 8 Pills	150.58€ 143.41€	Buy
Viagra Soft Tabs	100mg	60 + 6 Pills	152.94€ 145.66€	Buy
Tadalista Super Active	20mg	180 + 20 Pills	521.59€ 496.75€	Buy
Viagra Generic	50mg	270 + 8 Pills	198.48€ 189.03€	Buy
Kamagra Oral Jelly	100 mg	90 + 8 Sachets	303.56€ 289.10€	Buy
Cialis Super Active	20mg	180 + 20 Pills	521.59€ 496.75€	Buy
Kamagra Polo	100 mg	32 Pills	125.88€ 119.89€	Buy
Kamagra Polo	100 mg	84 + 4 Pills	244.49€ 232.85€	Buy
Viagra Generic	200mg	30 + 2 Pills	83.07€ 79.11€	Buy
Levitra Professional	20mg	90 + 2 Pills	304.49€ 289.99€	Buy
Cialis Super Active	20mg	20 + 4 Pills	92.35€ 87.95€	Buy

Yet, criticism of the little pink pills has come mainly from women’s organizations, who warn that the drug poses many problems.

When a drug became a movement

All these buy online lovegra drugs have triggered many discussions around social, cultural and even political issues, showing how medicines are more than just chemical substances. In Japan, for example, Viagra’s approval brought protests from women’s groups, who decried the high priority given to male erectile problems. The groups observed that it took six months for the government to approve Viagra and 34 years for a low-dose hormonal contraceptive (“the pill”). The market for these drugs has not just been men with erectile dysfunction, usually those who are middle-aged and elderly, but also young men. The drugs work by increasing blood flow to the penis, but young men claim other uses and buy the pills to enhance their “performance” or even to increase penis size. Instead, it works mainly on the brain to get a balance of chemicals to produce more pleasurable feelings. The drug comes close to being an antidepressant, which translates to possible side effects like sleepiness, dizziness and hypotension (low blood pressure). There are also concerns that drinking alcoholic beverages can increase the risks of those side effects.

The overlooked science of women’s desire

But those antidepressants, which raise levels of the neurotransmitter serotonin, are known to blunt libido. Addyi blocks certain cellular receptors from responding to serotonin. Women who took Addyi in a clinical study had an increase of about one sexually satisfying event per month compared with those taking a placebo. Critics say the small benefit is outweighed by the drug’s risks. Addyi will come with a prominent "boxed warning" about side effects, including among people with liver impairment or who take Addyi with alcohol or with medicines known as CYP3A4 inhibitors that include certain steroids.

Gluten Free

Originally developed by Germany's Boehringer Ingelheim under its chemical name flibanserin, it was first rejected by the FDA in 2010 after an advisory panel said the benefits did not outweigh the risks. Sprout acquired the drug, conducted additional studies and resubmitted the application. In 2013, the FDA rejected it again. The rejection sparked a lobbying campaign by Sprout, aided by some women's groups who accused the FDA of gender bias because it had approved Viagra for men - a charge the FDA vigorously rejected. The FDA approved Addyi despite a rocky relationship in recent years with the founders of Sprout. The women’s groups point out only one study has been made into possible alcohol interactions with the drug… and that the study involved 23 men and two women—yet another example of gender trouble in the world of pharmaceuticals.

Addyi is the #1 Prescribed Treatment for HSDD.1

"This is the biggest breakthrough in women's sexual health since the advent of 'the Pill'" for contraception, The National Consumers League said in a statement. "It validates (and) legitimizes female sexuality as an important component of health." But Public Citizen, a consumer watchdog group that testified against the drug earlier this year, predicted that Addyi will be pulled from the market within a few years because of "serious dangers to women, with little benefit" to them. "Unfortunately, we haven't heard the last of this drug." The FDA had twice rejected the Raleigh, North Carolina-based firm's drug. But the latest decision comes after an advisory panel concluded in June it should be approved with strict measures in place to ensure patients are fully aware of the risks. Sprout officials could not immediately be reached for comment.

Natures Craft 1000mg D-Mannose and Cranberry Supplement, UT and Bladder Health Support, 90 Capsules

The news sent shares of Palatin Technologies, which is creating a rival drug for HSDD, up about 30 percent to $1.21 in extended trade. Palatin's experimental treatment called libido booster women bremelanotide is now in late-stage trials and works differently from Addyi. It attempts to activate certain brain pathways. Palatin in a statement late Tuesday said its drug, if approved, would only be taken as needed, not on a daily basis like Addyi, thereby providing women "greater control and flexibility in their treatment." Unlike Viagra, which affects blood flow to the genitals, Addyi is meant to activate sexual impulses in the brain. It is similar to a class of other drugs known as selective serotonin reuptake inhibitors, or SSRI's, that include antidepressants such as Prozac. The bigger debates cluster around the issue of “a pill for every ill,” an old expression that can be modified as “a pill for every ill, made up or real.” In the first half of the 20th century, the world would rejoice whenever new drugs were discovered, mainly to fight infectious diseases.

See also

In this view, the pink pill works by mechanistically resetting desire to a more normal level—which also happens to be more in keeping with what is desired—and so the distress disappears. The complex and fundamentally interpersonal nature of sexuality, the differences between men and women, the larger social context of romantic ideals and expectations, standards of comparison, social pressure, and past experience: These issues and more are not so much denied as made irrelevant. Mysteriously, biologically, men and women want, or want to want, “the same thing.” WASHINGTON/NEW YORK (Reuters) - The first drug to treat low sexual desire in women won approval from U.S. health regulators on Tuesday, but with a warning about potentially dangerous low blood pressure and fainting side effects, especially when taken with alcohol. The U.S.

Gluten-Free

Food and Drug Administration said the pink pill, to be sold under the brand name Addyi and made by privately held Sprout Pharmaceuticals, will only be available through certified and specially trained health care professionals and pharmacies due to its safety issues. Addyi, whose chemical name is flibanserin, is designed for premenopausal women whose lack of sexual desire causes distress. The condition is formally known as hypoactive sexual desire disorder, or HSDD. The drug needs to be taken daily. Addyi has been nicknamed the "female Viagra" even though it does not work like Pfizer Inc's blockbuster Viagra pill for men that in 1998 became the first approved drug for erectile dysfunction. In the last two or three decades, we have seen the rise of “lifestyle drugs,” the best-selling ones being those for baldness and for erectile dysfunction.

How do you want your item?

The chief executive of Sprout, Cindy Whitehead, co-founded the company with her husband Robert Whitehead in 2011 after selling another small drugmaker they had founded called Slate Pharmaceuticals which had received repeated warnings from the FDA about its marketing tactics. Slate marketed an implantable testosterone pellet for men with low levels of the male sexual hormone, called Testopel. In one FDA warning letter, issued on March 24, 2010, the FDA said Slate had improperly inferred on its Testopel website and in a video that the testosterone product could help patients with depression, erectile dysfunction, diabetes and HIV. The Whiteheads could not be reached for comment late on Tuesday about Addyi's approval and their earlier encounters with the FDA. Our Standards: The Thomson Reuters Trust Principles.

Incidence not known

In 1998 the approval of a new drug by the US Food and Drug Administration (FDA) made front-page headlines. The drug was Viagra (generic name: sildanefil), for use in erectile dysfunction. It soon acquired names based on its color and shape—“little blue pills,” “blue diamond.” In the ensuing years, Viagra had “cousins”—Cialis (tadalafil) and Levitra (vardenafil)—which provided friendly competition. Just this week another FDA decision again made world headlines: the approval of the drug Addyl (flibanserin). And the media are already talking about “little pink pills,” almost as if the drug were color-coded for its target group of patients: women with hypoactive sexual desire disorder or HSDD. These conditions are not life-threatening, but there is a huge market for the drugs. Shortly after Viagra was approved in America, it was already being sold in the Philippines even without government approval.

• Pink pills may contain amino acids aiding mental clarity.
• They are sometimes used as part of female fitness supplements.
• The color pink is chosen for branding targeting women.
• Some pink supplements include ingredients for hair growth.
• They are marketed as mood boosters for emotional balance.
• Placebo effects may influence perceived benefits.
• Proper dosage instructions are essential for safety.
• Some products are combined with other health supplements.
• Pink pills are sometimes used in beauty routines.
• The market for such pills is rapidly expanding.
• Regulatory standards for pink pills vary by country.

One venerable Filipino congressman was even caught trying to smuggle in a suitcase filled with the blue diamonds, much more than he would need in a lifetime.

• Pink pills frequently focus on hormonal harmony.
• They sometimes include phytoestrogens like soy isoflavones.
• Women seeking natural solutions often prefer pink pills.
• Different brands offer unique blends of ingredients.
• Some pink pills are formulated specifically for postmenopausal women.
• They may help improve skin hydration and glow.
• Pink pills are sometimes combined with herbal tea routines.
• Awareness of quality and source is crucial.
• Consumers should research product certifications before purchase.
• Pink pills are part of a broader movement toward women’s health autonomy.
• Effectiveness often depends on individual health conditions.

Questions were raised about relying on pills for sexuality problems. While the physical aspect of erectile dysfunction is very real, and associated with age, smoking and illnesses like diabetes, there is also a strong psychosocial component for which counseling is as important as the pills, including dealing with “performance anxiety”.

Tip	Explanation	Frequency	Additional Notes
Follow recommended dosage	Avoid overdose, which can cause side effects	As per product instructions	Consult a healthcare provider if unsure
Maintain a balanced diet	Supplements work best with proper nutrition	Daily	Incorporate fruits, vegetables
Stay hydrated	Water helps absorb active ingredients	Throughout the day	Aim for 8 glasses per day
Use consistently	Results appear with regular use over time	Daily or as advised	Patience is key